ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,050Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 1269

$552K Total Retail Price of All Prescriptions

Rank: 118 out of 1269

599 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 7,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 349 323 1 3
LEVOTHYROXINE SODIUM 291 267 2 4
AMLODIPINE BESYLATE 257 247 3 2
FUROSEMIDE 252 233 4 5
LISINOPRIL 237 200 5 1
METOPROLOL TARTRATE 180 156 6 6
OMEPRAZOLE 169 143 7 8
PRAVASTATIN SODIUM 165 156 8 11
ATORVASTATIN CALCIUM 140 132 9 7
AZITHROMYCIN 137 110 10 42
ATENOLOL 128 128 11 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 108 11 33
HYDROCHLOROTHIAZIDE 117 107 13 10
TRAMADOL HCL 113 91 14 16
HYDROCODONE-ACETAMINOPHEN 108 79 S3 15 20
SERTRALINE HCL 99 97 16 23
CITALOPRAM HBR 96 91 17 21
LOSARTAN POTASSIUM 91 86 18 15
METFORMIN HCL 87 75 19 9
WARFARIN SODIUM 87 80 19 12
CIPROFLOXACIN HCL 79 73 21 66
METOPROLOL SUCCINATE 75 69 22 13
TAMSULOSIN HCL 67 53 23 31
VERAPAMIL ER 66 54 24 134
LOVASTATIN 66 62 24 30
PREDNISONE 66 58 24 45
PANTOPRAZOLE SODIUM 65 61 27 18
ZOLPIDEM TARTRATE 63 38 28 19
CLOPIDOGREL 61 61 29 32
POTASSIUM CHLORIDE 61 61 29 26
DONEPEZIL HCL 60 60 31 22
CLOTRIMAZOLE-BETAMETHASONE 58 38 32 175
LORAZEPAM 58 58 32 363
AMOXICILLIN 57 35 34 129
OXYCODONE-ACETAMINOPHEN 55 17 S2 35 44
PAROXETINE HCL 55 43 35 71
ALLOPURINOL 50 47 37 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.